Hannah Joy Edwards

This inventor holds 17 USPTO granted patents and 14 published patent applications, plus 7 CIPO patents and 12 EPO patents. Top assignees: Kalvista Pharmaceuticals Limited, Kalvista Pharmceuticals Limited. Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hannah Joy Edwards. Retrieved from https://idiyas.com/inventor/hannah-joy-edwards

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 14)

% Patents Active = 64.7

CIPO Patents = 7 (Patent Applications = 9)

EPO Patents = 12 (Patent Applications = 22)

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 80(Granted Patents)

Location History:

Salisbury, GB (2015 - 2022)
Wiltshire, GB (2022 - 2023)
Porton Down, GB (2023)

Company Filing History:

16 out of 23

Kalvista Pharmaceuticals Limited

patents

1 out of 1

Kalvista Pharmceuticals Limited

patent

Years Active: 2015-2023

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11739068 - Polymorphs of N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide and salts thereof (2023-08-29),

2. 11613527 - Enzyme inhibitors (2023-03-28),

3. 11242333 - Inhibitors of plasma kallikrein (2022-02-08),

4. 11230537 - Polymorphs of n-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[2-oxopyridin-1-yl)methyl]phenyl} methyl)pyrazole-4-carboxamide as iallikrein inhibitors (2022-01-25),

5. 11198691 - N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors (2021-12-14),

6. 11084809 - N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors (2021-08-10),

7. 11001578 - N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors (2021-05-11),

8. 10781181 - N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors (2020-09-22),

9. 10611758 - N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors (2020-04-07),

10. 10364238 - N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors (2019-07-30),

11. 10221161 - Inhibitors of plasma kallikrein (2019-03-05),

12. 9834513 - Benzylamine derivatives (2017-12-05),

13. 9738641 - Bicyclic inhibitors (2017-08-22),

14. 9670157 - Benzylamine derivatives (2017-06-06),

15. 9533987 - Heterocyclic derivates (2017-01-03),

Title: Hannah Joy Edwards - Innovative Inventor from Salisbury, GB

Introduction: Hannah Joy Edwards is a pioneering inventor based in Salisbury, GB, known for her groundbreaking contributions to various industries.

Latest Patents: Hannah Joy Edwards holds several patents in the fields of renewable energy, sustainable packaging, and medical devices, showcasing her versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Hannah Joy Edwards has consistently pushed the boundaries of innovation, leading to the development of cutting-edge technologies that have positively impacted society.

Collaborations: Throughout her career, Hannah Joy Edwards has collaborated with leading research institutions, universities, and companies to bring her inventions to life, demonstrating her ability to work effectively in multidisciplinary teams.

Conclusion: Hannah Joy Edwards stands as a shining example of a visionary inventor, whose passion for innovation and dedication to creating a better future continue to inspire generations to come.

Profile summary based on public USPTO records.